Ingen Technologies, Inc. engages in the manufacture of respiratory medical devices. The company is headquartered in Riverside, California. The company went IPO on 2001-07-11. The firm holds the manufacturing and marketing platforms to produce its core medical product line, referred to as Oxyview and Smart Nasal Cannula. The firm develops products for the treatment of chronic obstructive pulmonary disease (COPD), such as chronic bronchitis, emphysema and asthmatic bronchitis, all of which obstruct airflow from the lungs. The Company’s products include The Smart Nasal Cannula 206NCA (Adult Size), The Smart Nasal Cannula 203NCA (Adult Size), The Smart Nasal Cannula 206NCP (Child Size), The Smart Nasal Cannula 203NCP (Child Size), The Smart Nasal Cannula 206NC (Infant Size), The Smart Nasal Cannula 203NC (Infant Size), Oxyview 203A And Oxyview 206A.
Follow-Up Questions
Who is the CEO of Ingen Technologies Inc?
David Hanson is the Chief Executive Officer of Ingen Technologies Inc, joining the firm since 2013.
What is the price performance of IGNT stock?
The current price of IGNT is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Ingen Technologies Inc?
Ingen Technologies Inc belongs to Health Care industry and the sector is Health Care
What is Ingen Technologies Inc market cap?
Ingen Technologies Inc's current market cap is $36.7K
